- Home
- ARWR vs CHRD Comparison
ARWR vs CHRD Comparison
Compare ARWR & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | CHRD |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | 676 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.2B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | CHRD |
|---|---|---|
| Price | $73.78 | $131.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $83.40 | ★ $149.17 |
| AVG Volume (30 Days) | ★ 2.0M | 862.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $12.56 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.53 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.01 | $84.25 |
| 52 Week High | $87.83 | $151.95 |
Technical Indicators
Market Signals| Indicator | ARWR | CHRD |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 61.70 |
| Support Level | $70.05 | $131.54 |
| Resistance Level | $77.39 | $141.72 |
| Average True Range (ATR) | 3.85 | 3.63 |
| MACD | -1.18 | 2.29 |
| Stochastic Oscillator | 21.70 | 94.34 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.